CoChat
Cited by 216

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Growth factor involvement in progression of prostate cancer

Russell, Pamela J, Bennett, Suzanne, Stricker, Phillip · 1998 · Clinical Chemistry

Abstract

Understanding how the regulation of growth factor pathways alters during prostate cancer (PC) progression may enable researchers to develop targeted therapeutic strategies for advanced disease. PC progression involves the shifting of cells from androgen-dependent growth to an androgen-independent state, sometimes with the loss or mutation of the androgen receptors in PC cells. Both autocrine and paracrine pathways are up-regulated in androgen-independent tumors and may replace androgens as primary growth stimulatory factors in cancer progression. Our discussion focuses on growth factor families that maintain homeostasis between epithelial and stromal cells in the normal prostate and that undergo changes as PC progresses, often making stromal cells redundant. These growth factors include fibroblast growth factor, insulin-like growth factors, epidermal growth factor, transforming growth factor α, retinoic acid, vitamin D3, and the transforming growth factor β families. We review their role in normal prostate development and in cancer progression, using evidence from clinical specimens and models of PC cell growth.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/clinchem/44.4.705

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 227

  1. 1985, Cancer J Clin, 35, 36, 10.3322/canjclin.35.1.36 · DOI · Paper page
  2. 1994, Incidence and Mortality, 58
  3. 1990, Cancer J Clin, 44, 7
  4. 1986, Lancet, i, 60
  5. 1995, Urology, 46, 757, 10.1016/S0090-4295(99)80339-2 · DOI
  6. 1994, Urology, 43, 60, 10.1016/S0090-4295(94)80264-5 · doi:10.1016/s0090-4295(94)80264-5
  7. 1993, J Urol, 150, 400, 10.1016/S0022-5347(17)35493-9 · doi:10.1016/s0022-5347(17)35493-9
  8. 1994, N Engl J Med, 330, 242, 10.1056/NEJM199401273300403 · DOI · Paper page
  9. 1993, Prostate diseases, 28
  10. 1996, Prostate, 28, 98, 10.1002/(SICI)1097-0045(199602)28:2<98::AID-PROS4>3.0.CO;2-J · DOI · Paper page
  11. 1992, Campbell’s urology, 221
  12. 1987, Endocr Rev, 8, 338, 10.1210/edrv-8-3-338 · DOI · Paper page
  13. 1997, Principles and practice of genitourinary oncology, 367
  14. 1994, N Engl J Med, 331, 996, 10.1056/NEJM199410133311507 · DOI · Paper page
  15. 1988, Mol Endocrinol, 2, 1265, 10.1210/mend-2-12-1265 · DOI · Paper page
  16. 1996, Prostate, 6, 52
  17. 1991, Cancer Surv, 11, 91
  18. 1991, Cancer, 67, 3057, 10.1002/1097-0142(19910615)67:12<3057::AID-CNCR2820671221>3.0.CO;2-S · DOI
  19. 1992, J Urol, 147, 798, 10.1016/S0022-5347(17)37389-5 · DOI
  20. 1996, J Endocrinol, 151, 1, 10.1677/joe.0.1510001 · DOI
  21. 1995, N Engl J Med, 332, 1393, 10.1056/NEJM199505253322101 · DOI · Paper page
  22. 1994, Cancer Res, 54, 2861
  23. 1990, Biochim Biophys Acta, 1052, 187, 10.1016/0167-4889(90)90075-O · DOI · Paper page
  24. 1994, Biochem Biophys Res Commun, 198, 74, 10.1006/bbrc.1994.1011 · DOI · Paper page
  25. 1990, Mol Endocrinol, 4, 7211
  26. 1991, J Biol Chem, 226, 510
  27. 1994, Cancer Res, 54, 5474
  28. 1988, Mol Cell Endocrinol, 60, 101, 10.1016/0303-7207(88)90124-4 · doi:10.1016/0303-7207(88)90124-4
  29. 1996, Prostate, 28, 219, 10.1002/(SICI)1097-0045(199604)28:4<219::AID-PROS2>3.0.CO;2-8 · doi:10.1002/(sici)1097-0045(199604)28:4<219::aid-pros2>3.0.co;2-8
  30. 1995, Microsc Res Tech, 30, 333, 10.1002/jemt.1070300408 · doi:10.1002/jemt.1070300408
  31. 1996, Int J Cancer, 67, 573, 10.1002/(SICI)1097-0215(19960807)67:4<573::AID-IJC17>3.0.CO;2-8 · doi:10.1002/(sici)1097-0215(19960807)67:4<573::aid-ijc17>3.0.co;2-8
  32. 1990, Cancer Res, 90, 3748
  33. 1985, Cancer Surv, 4, 683
  34. 1993, Hum Pathol, 24, 4, 10.1016/0046-8177(93)90055-L · DOI · Paper page
  35. 1996, Urol Oncol, 2, 131, 10.1016/S1078-1439(96)00078-6 · DOI
  36. 1991, Mol Endocrinol, 5, 503, 10.1210/mend-5-4-503 · doi:10.1210/mend-5-4-503
  37. 1996, Cancer Res, 56, 3359
  38. 1992, Mol Endocrinol, 6, 15
  39. 1996, Cancer Res, 56, 44
  40. 1996, Clin Cancer Res, 2, 1255
  41. 1995, Urol Oncol, 1, 252, 10.1016/1078-1439(96)00028-2 · DOI
  42. 1988, FASEB J, 2, A875
  43. 1995, Acta Pathol Microbiol Immunol Scand, 103, 140, 10.1111/j.1699-0463.1995.tb01089.x · DOI
  44. 1992, Endocrinology, 130, 2955, 10.1210/endo.130.5.1374018 · DOI
  45. 1989, Prostate, 15, 355, 10.1002/pros.2990150408 · doi:10.1002/pros.2990150408
  46. 1992, Cancer Res, 52, 571
  47. 1993, Mol Cell Biol, 13, 4513, 10.1128/MCB.13.8.4513 · DOI · Paper page
  48. 1990, EMBO J, 9, 907, 10.1002/j.1460-2075.1990.tb08188.x · DOI · Paper page
  49. 1990, J Natl Cancer Inst, 82, 4, 10.1093/jnci/82.1.4 · DOI · Paper page
  50. 1989, Cancer Res, 49, 2485
  51. 1991, Cancer Surv, 11, 165
  52. 1992, Mol Endocrinol, 6, 2123
  53. 1992, Proc Natl Acad Sci U S A, 89, 3305, 10.1073/pnas.89.8.3305 · DOI
  54. 1995, Exp Mol Pathol, 63, 52, 10.1006/exmp.1995.1030 · doi:10.1006/exmp.1995.1030
  55. 1997, Oncogene, 15, 1115, 10.1038/sj.onc.1201256 · doi:10.1038/sj.onc.1201256
  56. 1996, J Steroid Biochem Mol Biol, 57, 173, 10.1016/0960-0760(95)00259-6 · doi:10.1016/0960-0760(95)00259-6
  57. 1991, J Clin Endocrinol Metab, 73, 401, 10.1210/jcem-73-2-401 · DOI · Paper page
  58. 1996, J Clin Endocrinol Metab, 81, 612
  59. 1996, Int J Urol, 3, 39, 10.1111/j.1442-2042.1996.tb00628.x · DOI
  60. 1993, J Clin Endocrinol Metab, 77, 229
  61. 1995, Endocrinology, 136, 1040, 10.1210/endo.136.3.7532576 · DOI
  62. 1996, Eur J Endocrinol, 134, 591, 10.1530/eje.0.1340591 · DOI
  63. 1986, Clin Sci, 70, 359, 10.1042/cs0700359 · doi:10.1042/cs0700359
  64. 1988, Mol Cell Endocrinol, 56, 21, 10.1016/0303-7207(88)90004-4 · DOI
  65. 1988, Biochem Int, 17, 311
  66. 1996, Prostate, 28, 139, 10.1002/(SICI)1097-0045(199603)28:3<139::AID-PROS1>3.0.CO;2-A · doi:10.1002/(sici)1097-0045(199603)28:3<139::aid-pros1>3.0.co;2-a
  67. 1988, J Urol, 139, 857, 10.1016/S0022-5347(17)42662-0 · doi:10.1016/s0022-5347(17)42662-0
  68. 1993, Br J Cancer, 67, 152, 10.1038/bjc.1993.26 · doi:10.1038/bjc.1993.26
  69. 1993, Prostate, 23, 9, 10.1002/pros.2990230103 · doi:10.1002/pros.2990230103
  70. 1996, Hum Pathol, 27, 688, 10.1016/S0046-8177(96)90399-8 · DOI
  71. 1994, J Urol, 152, 2120, 10.1016/S0022-5347(17)32335-2 · DOI
  72. 1994, Prostate, 24, 46, 10.1002/pros.2990240110 · DOI
  73. 1996, Int J Urol, 3, 39, 10.1111/j.1442-2042.1996.tb00628.x · DOI
  74. 1994, Prostate, 24, 204, 10.1002/pros.2990240406 · DOI
  75. 1992, J Urol, 147, 1444, 10.1016/S0022-5347(17)37590-0 · DOI
  76. 1992, Cancer Res, 52, 5403
  77. 1995, Urology, 45, 542, 10.1016/S0090-4295(99)80034-X · DOI · Paper page
  78. 1994, J Urol, 151, 1396, 10.1016/S0022-5347(17)35267-9 · DOI
  79. 1980, Prog Clin Biol Res, 37, 379
  80. 1963, Natl Cancer Inst Monogr, 12, 351
  81. 1987, Current approaches to the study of prostate cancer, 513
  82. 1975, Cancer Res, 35, 1840
  83. 1986, Prostate, 9, 261, 10.1002/pros.2990090306 · DOI · Paper page
  84. 1975, Cancer Res, 35, 2935
  85. 1977, Cancer Res, 37, 1929
  86. 1980, Prog Clin Biol Res, 37, 325
  87. 1985, Anticancer Res, 5, 193
  88. 1989, Int J Cancer, 43, 1179, 10.1002/ijc.2910430636 · DOI
  89. 1973, J Natl Cancer Inst, 51, 1235, 10.1093/jnci/51.4.1235 · doi:10.1093/jnci/51.4.1235
  90. 1985, Prostate, 6, 389, 10.1002/pros.2990060407 · doi:10.1002/pros.2990060407
  91. 1994, Cancer Res, 54, 626
  92. 1975, J Natl Cancer Inst, 55, 177, 10.1093/jnci/55.1.177 · doi:10.1093/jnci/55.1.177
  93. 1981, J Natl Cancer Inst, 66, 565
  94. 1964, Cancer Res, 25, 1168
  95. 1972, Biochem J, 127, 561, 10.1042/bj1270561 · doi:10.1042/bj1270561
  96. 1989, Cell, 56, 917, 10.1016/0092-8674(89)90625-9 · DOI · Paper page
  97. 1983, Tissue Antigens, 21, 227, 10.1111/j.1399-0039.1983.tb00162.x · doi:10.1111/j.1399-0039.1983.tb00162.x
  98. 1979, Invest Urol, 17, 16
  99. 1977, Cancer Res, 37, 4049
  100. 1980, Prog Clin Biol Res, 37, 115
  101. 1994, Int J Cancer, 57, 406, 10.1002/ijc.2910570319 · DOI · Paper page
  102. 1994, Cancer Res, 54, 2577
  103. 1996, Proc Natl Acad Sci U S A, 93, 11802, 10.1073/pnas.93.21.11802 · DOI · Paper page
  104. 1996, Cancer Res, 56, 3042
  105. 1980, Prostate, 1, 95, 10.1002/pros.2990010113 · DOI
  106. 1993, Prostate, 23, 149, 10.1002/pros.2990230208 · doi:10.1002/pros.2990230208
  107. 1984, J Urol, 132, 384, 10.1016/S0022-5347(17)49633-9 · DOI
  108. 1996, Int J Cancer, 67, 785, 10.1002/(SICI)1097-0215(19960917)67:6<785::AID-IJC6>3.0.CO;2-N · doi:10.1002/(sici)1097-0215(19960917)67:6<785::aid-ijc6>3.0.co;2-n
  109. 1987, Cancer Genet Cytogenet, 26, 165, 10.1016/0165-4608(87)90143-9 · doi:10.1016/0165-4608(87)90143-9
  110. 1988, Mol Cell Endocrinol, 55, 167, 10.1016/0303-7207(88)90131-1 · doi:10.1016/0303-7207(88)90131-1
  111. 1983, J Cell Biol, 96, 1662, 10.1083/jcb.96.6.1662 · DOI · Paper page
  112. 1990, J Steroid Biochem Mol Biol, 37, 843, 10.1016/0960-0760(90)90430-S · doi:10.1016/0960-0760(90)90430-s
  113. 1987, J Urol, 137, 1304, 10.1016/S0022-5347(17)44488-0 · DOI
  114. 1996, Clin Cancer Res, 2, 1627
  115. 1991, Cancer Res, 51, 3753
  116. 1992, J Urol, 147, 1151, 10.1016/S0022-5347(17)37506-7 · DOI · Paper page
  117. 1991, Cancer Surv, 11, 91
  118. 1993, Cancer Res, 53, 2852
  119. 1992, Endocrinology, 131, 3045, 10.1210/endo.131.6.1446639 · doi:10.1210/endo.131.6.1446639
  120. 1990, Cell, 61, 1121, 10.1016/0092-8674(90)90075-P · DOI · Paper page
  121. 1995, Proc Natl Acad Sci U S A, 92, 3439, 10.1073/pnas.92.8.3439 · DOI · Paper page
  122. 1996, Cancer Res, 56, 4894
  123. 1996, Cancer Res, 56, 4096
  124. 1990, Peptide growth factors and their receptors: handbook of experimental pharmacology. Volume 95–1, 419
  125. 1994, World J Urol, 12, 96
  126. 1989, Mol Endocrinol, 3, 1977, 10.1210/mend-3-12-1977 · DOI · Paper page
  127. 1990, Ann N Y Acad Sci, 593, 208, 10.1111/j.1749-6632.1990.tb16113.x · DOI
  128. 1993, Science, 260, 1335, 10.1126/science.8388126 · DOI · Paper page
  129. 1994, J Biol Chem, 269, 30688, 10.1016/S0021-9258(18)43868-9 · DOI
  130. 1995, Eur J Clin Invest, 25, 959, 10.1111/j.1365-2362.1995.tb01974.x · DOI
  131. 1997, Int J Hematol, 65, 97, 10.1016/S0925-5710(96)00542-7 · doi:10.1016/s0925-5710(96)00542-7
  132. 1990, J Biol Chem, 265, 21393, 10.1016/S0021-9258(18)45745-6 · DOI · Paper page
  133. 1990, J Biol Chem, 265, 7709, 10.1016/S0021-9258(19)38983-5 · DOI · Paper page
  134. 1984, Nature, 309, 418, 10.1038/309418a0 · DOI · Paper page
  135. 1991, Growth Factors, 4, 265, 10.3109/08977199109043912 · DOI · Paper page
  136. 1990, J Cell Physiol, 144, 108, 10.1002/jcp.1041440114 · DOI · Paper page
  137. 1990, Cancer Metastasis Rev, 9, 227, 10.1007/BF00046362 · DOI
  138. 1985, Science, 230, 1385, 10.1126/science.4071057 · DOI · Paper page
  139. 1991, In Vitro Cell Dev Biol, 27A, 437
  140. 1989, Science, 245, 752, 10.1126/science.2475908 · DOI · Paper page
  141. 1989, Endocr Rev, 10, 68, 10.1210/edrv-10-1-68 · DOI · Paper page
  142. 1989, Cell, 59, 235, 10.1016/0092-8674(89)90281-X · DOI · Paper page
  143. 1990, Recent Prog Horm Res, 46, 99
  144. 1991, Cancer Surv, 11, 147
  145. 1988, EMBO J, 7, 3737, 10.1002/j.1460-2075.1988.tb03257.x · DOI · Paper page
  146. 1989, EMBO J, 6, 1899
  147. 1990, Cell, 53, 515
  148. 1990, Cell, 62, 175, 10.1016/0092-8674(90)90251-9 · DOI · Paper page
  149. 1991, EMBO J, 10, 1091, 10.1002/j.1460-2075.1991.tb08049.x · DOI · Paper page
  150. 1993, Cancer Res, 53, 3193
  151. 1989, Mol Cell Endocrinol, 62, 79, 10.1016/0303-7207(89)90115-9 · doi:10.1016/0303-7207(89)90115-9
  152. 1987, Biochemistry, 26, 2406, 10.1021/bi00383a002 · doi:10.1021/bi00383a002
  153. 1989, Mol Cell Biol, 9, 5508, 10.1128/MCB.9.12.5508 · DOI · Paper page
  154. 1997, Clin Exp Metastasis, 15, 41
  155. 1984, Cancer Res, 44, 1998
  156. 1989, Growth Factors, 1, 237
  157. 1989, Urol Int, 44, 71, 10.1159/000281473 · doi:10.1159/000281473
  158. 1992, J Cell Biochem Suppl, 16, 99
  159. 1992, Cancer Res, 33, 1651
  160. 1990, Prostate, 16, 209, 10.1002/pros.2990160304 · DOI
  161. 1989, Prostate, 15, 177, 10.1002/pros.2990150211 · DOI
  162. 1992, Br J Cancer, 65, 177, 10.1038/bjc.1992.37 · doi:10.1038/bjc.1992.37
  163. 1993, Mol Cell Biochem, 126, 151, 10.1007/BF00925693 · DOI
  164. 1994, Steroids, 59, 412, 10.1016/0039-128X(94)90010-8 · doi:10.1016/0039-128x(94)90010-8
  165. 1994, Surg Oncol, 3, 237, 10.1016/0960-7404(94)90039-6 · doi:10.1016/0960-7404(94)90039-6
  166. 1992, Br J Cancer, 65, 177, 10.1038/bjc.1992.37 · doi:10.1038/bjc.1992.37
  167. 1994, Br J Urol, 74, 214, 10.1111/j.1464-410X.1994.tb16589.x · doi:10.1111/j.1464-410x.1994.tb16589.x
  168. 1994, Prostate, 25, 199, 10.1002/pros.2990250405 · doi:10.1002/pros.2990250405
  169. 1990, J Urol, 143, 1272, 10.1016/S0022-5347(17)40253-9 · DOI
  170. 1991, J Steroid Biochem Mol Biol, 40, 199, 10.1016/0960-0760(91)90183-6 · doi:10.1016/0960-0760(91)90183-6
  171. 1991, J Steroid Biochem Mol Biol, 40, 193, 10.1016/0960-0760(91)90182-5 · DOI
  172. 1996, Prostate, 28, 392, 10.1002/(SICI)1097-0045(199606)28:6<392::AID-PROS9>3.0.CO;2-C · DOI · Paper page
  173. 1991, Mol Cell Biol, 11, 4627, 10.1128/MCB.11.9.4627 · DOI · Paper page
  174. 1992, Mol Cell Biol, 12, 82, 10.1128/MCB.12.1.82 · DOI · Paper page
  175. 1992, J Neurosci, 12, 142, 10.1523/JNEUROSCI.12-01-00142.1992 · DOI · Paper page
  176. 1986, EMBO J, 5, 2523, 10.1002/j.1460-2075.1986.tb04530.x · DOI · Paper page
  177. 1991, Growth Factors, 4, 277, 10.3109/08977199109043913 · DOI
  178. 1985, Regul Pept, 12, 201, 10.1016/0167-0115(85)90061-8 · DOI
  179. 1987, Nature, 325, 257, 10.1038/325257a0 · DOI · Paper page
  180. 1987, Nature, 326, 197, 10.1038/326197a0 · DOI · Paper page
  181. 1987, Curr Eye Res, 6, 1165, 10.3109/02713688709034890 · doi:10.3109/02713688709034890
  182. 1987, J Cell Biol, 104, 635, 10.1083/jcb.104.3.635 · DOI · Paper page
  183. 1996, Prostate, 28, 352, 10.1002/(SICI)1097-0045(199606)28:6<352::AID-PROS3>3.0.CO;2-C · doi:10.1002/(sici)1097-0045(199606)28:6<352::aid-pros3>3.0.co;2-c
  184. 1993, Prostate, 22, 183, 10.1002/pros.2990220302 · DOI
  185. 1989, Cancer Res, 49, 5889
  186. 1992, J Steroid Biochem Mol Biol, 41, 659, 10.1016/0960-0760(92)90400-D · doi:10.1016/0960-0760(92)90400-d
  187. 1994, Prostate, 25, 206, 10.1002/pros.2990250406 · doi:10.1002/pros.2990250406
  188. 1993, Jpn J Cancer Res, 84, 1300, 10.1111/j.1349-7006.1993.tb02838.x · doi:10.1111/j.1349-7006.1993.tb02838.x
  189. 1993, Am J Pathol, 43, 401
  190. 1983, Cancer, 53, 246
  191. 1996, Int J Dev Biol, 40, 941
  192. 1994, Growth Factors, 10, 269, 10.3109/08977199409010993 · DOI
  193. 1996, Growth Regul, 6, 22
  194. 1993, Cancer Res, 53, 1102
  195. 1993, Prostate, 22, 243, 10.1002/pros.2990220307 · DOI · Paper page
  196. 1996, Endocrinology, 137, 2676, 10.1210/endo.137.7.8770886 · doi:10.1210/endo.137.7.8770886
  197. 1995, J Bone Miner Res, 10, 788, 10.1002/jbmr.5650100516 · doi:10.1002/jbmr.5650100516
  198. 1987, Nutr Cancer, 9, 123, 10.1080/01635588709513919 · DOI
  199. 1992, Mol Biol Cell, 3, 189, 10.1091/mbc.3.2.189 · DOI
  200. 1989, Cell Regul, 1, 87, 10.1091/mbc.1.1.87 · DOI · Paper page

200 of 227 shown

Cited by

See all 216

Metadata

Authors
Russell, P. J., Bennett, S., & Stricker, P.
Venue
Clinical Chemistry
Published
1998-04-01
Volume
44
Issue
4
Pages
705-723
ISSN
  • 0009-9147 (ISSN-L)
  • 1530-8561
OpenAlex
W4298355764
Cited by
216
References
2
FWCI
14.88
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.